Gp130 Signaling in NOD2-Driven Crohn's Disease: A Key Player in Fibrosis and a Novel Target for Refractory Patients
Gastroenterology
.
2021 Sep;161(3):1063-1065.
doi: 10.1053/j.gastro.2021.06.027.
Epub 2021 Jun 17.
Authors
Matilde Bustos
1
,
David Carneros
1
,
Maria D Giraldez
1
Affiliation
1
Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.
PMID:
34146574
DOI:
10.1053/j.gastro.2021.06.027
No abstract available